Costs of colorectal cancer in different states of the disease

References

• Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. [cited 2014 Jun 27]. Available from: globocan.iarc.fr
   Google Scholar
• Finnish Cancer Registry, Cancer Statistics, updated on 24/4/2014 [Internet]. [cited 2014 Jun 27]. Available from: www.cancerregistry.fi
   Google Scholar
• Järvinen H, Kasvaimet LA. In: Färkkilä M, Isoniemi H, Kaukinen K, Puolakkainen P, editors. Gastroenterologia ja hepatologia (in Finnish), 2nd ed. Helsinki: Duodecim; 2013.
   Google Scholar
• Kalseth J, Halsteinli V, Halvorsen T, Kalseth B, Anthun K, Peltola M. Costs of cancer in the Nordic countries. A comparative study of health care costs and public income loss compensation payments related to cancer in the Nordic countries in 2007. Trondheim: SINTEF Technology and Society; 2011.
   Google Scholar
• Färkkilä N, Sintonen H, Saarto T, Järvinen H, Hänninen J, Taari K, et al. Health-related quality of life in colorectal cancer. Colorectal Dis 2013;15:e215–22.
   PubMed Web of Science ®Google Scholar
• Torvinen S, Färkkilä N, Sintonen H, Saarto T, Roine RP, Taari K. Health-related quality of life in prostate cancer. Acta Oncol 2013;52:1094–101.
   PubMed Web of Science ®Google Scholar
• Färkkilä N, Torvinen S, Roine RP, Sintonen H, Hänninen J, Taari K, et al. Health-related quality of life among breast, prostate, and colorectal cancer patients with end-stage disease. Qual Life Res 2014;23:1387–94.
   PubMed Web of Science ®Google Scholar
• Liljas B. How to calculate indirect costs in economic evaluations. Pharmacoeconomics 1998;13:1–7.
   PubMed Web of Science ®Google Scholar
• Hoefman RJ, van Exel J, Brouwer W. How to include informal care in economic evaluations. Pharmacoeconomics 2013;31:1105–19.
   PubMed Web of Science ®Google Scholar
• Official statistics of Finland. Structure of earnings 2010. Helsinki: Statistics of Finland; 2011.
   Google Scholar
• Sintonen H. The 15D instrument of health-related quality of life: Properties and applications. Ann Med 2001;33:328–36.
   PubMed Web of Science ®Google Scholar
• Lidgren M, Wilking N, Jonsson B, Rehnberg C. Resource use and costs associated with different states of breast cancer. Int J Technol Assess Health Care 2007;23:223–31.
   PubMed Web of Science ®Google Scholar
• Lang K, Lines LM, Lee DW, Korn JR, Earle CC, Menzin J. Lifetime and treatment-phase costs associated with colorectal cancer: Evidence from SEER-Medicare data. Clin Gastroenterol Hepatol 2009;7:198–204.
   PubMed Web of Science ®Google Scholar
• Shugarman LR, Bird CE, Schuster CR, Lynn J. Age and gender differences in Medicare expenditures at the end of life for colorectal cancer decedents. J Womens Health (Larchmt) 2007;16:214–27.
   PubMed Web of Science ®Google Scholar
• Macafee DA, West J, Scholefield JH, Whynes DK. Hospital costs of colorectal cancer care. Clin Med Oncol 2009;3:27–37.
   PubMedGoogle Scholar
• Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603–7.
   PubMed Web of Science ®Google Scholar
• Kronborg O, Jorgensen OD, Fenger C, Rasmussen M. Randomized study of biennial screening with a faecal occult blood test: Results after nine screening rounds. Scand J Gastroenterol 2004;39:846–51.
   PubMed Web of Science ®Google Scholar
• Van den Berg B, Brouwer W, van Exel J, Koopmanschap M, van den Bos GA, Rutten F. Economic valuation of informal care: Lessons from the application of the opportunity costs and proxy good methods. Soc Sci Med 2006;62:835–45.
   PubMed Web of Science ®Google Scholar
• Yabroff KR, Borowski L, Lipscomb J. Economic studies in colorectal cancer: Challenges in measuring and comparing costs. J Natl Cancer Inst Monogr 2013;46:62–78.
   Google Scholar
• Howard DH, Kauh J, Lipscomb J. The value of new chemotherapeutic agents for metastatic colorectal cancer. Arch Intern Med 2010;170:537–42.
   PubMed Web of Science ®Google Scholar
• Howard DH, Tangka FK, Seeff LC, Richardson LC, Ekwueme DU. The impact of detection and treatment on lifetime medical costs for patients with precancerous polyps and colorectal cancer. Health Econ 2009;18:1381–93.
   PubMed Web of Science ®Google Scholar
• Maroun J, Ng E, Berthelot JM, Le PC, Dahrouge S, Flanagan WM, et al. Lifetime costs of colon and rectal cancer management in Canada. Chronic Dis Can 2003;24: 91–101.
   PubMedGoogle Scholar
• Yabroff KR, Warren JL, Banthin J, Schrag D, Mariotto A, Lawrence W, et al. Comparison of approaches for estimating prevalence costs of care for cancer patients: What is the impact of data source? Med Care 2009;47:S64–9.
   PubMed Web of Science ®Google Scholar
• Luo Z, Bradley CJ, Dahman BA, Gardiner JC. Colon cancer treatment costs for Medicare and dually eligible beneficiaries. Health Care Financ Rev 2010;31:35–50.
   PubMed Web of Science ®Google Scholar
• Clerc L, Jooste V, Lejeune C, Schmitt B, Arveux P, Quantin C, et al. Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France. Eur J Health Econ 2008;9:361–7.
   PubMed Web of Science ®Google Scholar
• Ramsey SD, Mandelson MT, Berry K, Etzioni R, Harrison R. Cancer-attributable costs of diagnosis and care for persons with screen-detected versus symptom-detected colorectal cancer. Gastroenterology 2003;125:1645–50.
   PubMed Web of Science ®Google Scholar
• Bouvier V, Reaud JM, Gignoux M, Launoy G. Cost of diagnostic and therapeutic management of colorectal cancer according to stage at diagnosis in the Calvados Department, France. Eur J Health Econ 2003;4:102–6.
   PubMedGoogle Scholar
• Lejeune C, Binquet C, Bonnetain F, Mahboubi A, Abrahamowicz M, Moreau T, et al. Estimating the cost related to surveillance of colorectal cancer in a French population. Eur J Health Econ 2009;10:409–19.
   PubMed Web of Science ®Google Scholar
• Korner H, Soreide K, Stokkeland PJ, Soreide JA. Systematic follow-up after curative surgery for colorectal cancer in Norway: A population-based audit of effectiveness, costs, and compliance. J Gastrointest Surg 2005;9:320–8.
   PubMed Web of Science ®Google Scholar
• Koroukian SM, Beaird H, Madigan E, Diaz M. End-of-life expenditures by Ohio Medicaid beneficiaries dying of cancer. Health Care Financ Rev 2006;28:65–80.
   PubMed Web of Science ®Google Scholar
• Yabroff KR, Lamont EB, Mariotto A, Warren JL, Topor M, Meekins A, et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst 2008;100: 630–41.
   PubMed Web of Science ®Google Scholar
• Yabroff KR, Kim Y. Time costs associated with informal caregiving for cancer survivors. Cancer 2009;115:4362–73.
   PubMed Web of Science ®Google Scholar
• Hayman JA, Langa KM, Kabeto MU, Katz SJ, DeMonner SM, Chernew ME, et al. Estimating the cost of informal caregiving for elderly patients with cancer. J Clin Oncol 2001;19:3219–25.
   PubMed Web of Science ®Google Scholar